176 related articles for article (PubMed ID: 27053095)
1. The impact of serial radon and hyperthermia exposure in a therapeutic adit on pivotal cytokines of bone metabolism in rheumatoid arthritis and osteoarthritis.
Lange U; Dischereit G; Tarner I; Frommer K; Neumann E; Müller-Ladner U; Kürten B
Clin Rheumatol; 2016 Nov; 35(11):2783-2788. PubMed ID: 27053095
[TBL] [Abstract][Full Text] [Related]
2. Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis.
Skoumal M; Kolarz G; Haberhauer G; Woloszczuk W; Hawa G; Klingler A
Rheumatol Int; 2005 Nov; 26(1):63-9. PubMed ID: 15889303
[TBL] [Abstract][Full Text] [Related]
3. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis.
Xu S; Wang Y; Lu J; Xu J
Rheumatol Int; 2012 Nov; 32(11):3397-403. PubMed ID: 22057136
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.
Catrina AI; af Klint E; Ernestam S; Catrina SB; Makrygiannakis D; Botusan IR; Klareskog L; Ulfgren AK
Arthritis Rheum; 2006 Jan; 54(1):76-81. PubMed ID: 16385498
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha promotes the expression of osteoprotegerin in rheumatoid synovial fibroblasts.
Kubota A; Hasegawa K; Suguro T; Koshihara Y
J Rheumatol; 2004 Mar; 31(3):426-35. PubMed ID: 14994384
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of total flavonoids of Astragalus against adjuvant-induced arthritis in rats by regulating OPG/RANKL/NF-κB pathway.
Liu XY; Xu L; Wang Y; Li JX; Zhang Y; Zhang C; Wang SS; Zhang XM
Int Immunopharmacol; 2017 Mar; 44():105-114. PubMed ID: 28092862
[TBL] [Abstract][Full Text] [Related]
7. 1,25-dihydroxyvitamin D3 inhibits the RANKL pathway and impacts on the production of pathway-associated cytokines in early rheumatoid arthritis.
Luo J; Wen H; Guo H; Cai Q; Li S; Li X
Biomed Res Int; 2013; 2013():101805. PubMed ID: 23710436
[TBL] [Abstract][Full Text] [Related]
8. Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis.
Remuzgo-Martínez S; Genre F; López-Mejías R; Ubilla B; Mijares V; Pina T; Corrales A; Blanco R; Martín J; Llorca J; González-Gay MA
Sci Rep; 2016 Jul; 6():29713. PubMed ID: 27403809
[TBL] [Abstract][Full Text] [Related]
9. Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures.
Giganti MG; Liuni F; Celi M; Gasbarra E; Zenobi R; Tresoldi I; Modesti A; Bei R; Tarantino U
J Biol Regul Homeost Agents; 2012; 26(4):671-80. PubMed ID: 23241117
[TBL] [Abstract][Full Text] [Related]
10. The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction.
Geusens PP; Landewé RB; Garnero P; Chen D; Dunstan CR; Lems WF; Stinissen P; van der Heijde DM; van der Linden S; Boers M
Arthritis Rheum; 2006 Jun; 54(6):1772-7. PubMed ID: 16736519
[TBL] [Abstract][Full Text] [Related]
11. High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment.
Ziolkowska M; Kurowska M; Radzikowska A; Luszczykiewicz G; Wiland P; Dziewczopolski W; Filipowicz-Sosnowska A; Pazdur J; Szechinski J; Kowalczewski J; Rell-Bakalarska M; Maslinski W
Arthritis Rheum; 2002 Jul; 46(7):1744-53. PubMed ID: 12124857
[TBL] [Abstract][Full Text] [Related]
12. Periodontal disease influences osteoclastogenic bone markers in subjects with and without rheumatoid arthritis.
Panezai J; Ghaffar A; Altamash M; Engström PE; Larsson A
PLoS One; 2018; 13(6):e0197235. PubMed ID: 29889832
[TBL] [Abstract][Full Text] [Related]
13. Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand mRNA expression in patients with rheumatoid arthritis and healthy controls.
Vanderborght A; Linsen L; Thewissen M; Geusens P; Raus J; Stinissen P
J Rheumatol; 2004 Aug; 31(8):1483-90. PubMed ID: 15290725
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of RANKL/OPG, dickkopf-1 and bone marrow edema in rheumatoid arthritis with the complaint of knee pain].
Li M; Wu XH; Yin G; Xie QB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):276-9. PubMed ID: 25924445
[TBL] [Abstract][Full Text] [Related]
15. Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate.
Hensvold AH; Joshua V; Li W; Larkin M; Qureshi F; Israelsson L; Padyukov L; Lundberg K; Defranoux N; Saevarsdottir S; Catrina AI
Arthritis Res Ther; 2015 Sep; 17(1):239. PubMed ID: 26337028
[TBL] [Abstract][Full Text] [Related]
16. Effect of iguratimod and methotrexate on RANKL and OPG expression in serum and IL-1β-induced fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Wang XT; Li P; Xu TS; Ding R; Zhang X; Bi LQ
Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):44-50. PubMed ID: 27894399
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis.
Feuerherm AJ; Borset M; Seidel C; Sundan A; Leistad L; Ostensen M; Faxvaag A
Scand J Rheumatol; 2001; 30(4):229-34. PubMed ID: 11578019
[TBL] [Abstract][Full Text] [Related]
18. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients.
Kotake S; Udagawa N; Hakoda M; Mogi M; Yano K; Tsuda E; Takahashi K; Furuya T; Ishiyama S; Kim KJ; Saito S; Nishikawa T; Takahashi N; Togari A; Tomatsu T; Suda T; Kamatani N
Arthritis Rheum; 2001 May; 44(5):1003-12. PubMed ID: 11352231
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis.
Świerkot J; Gruszecka K; Matuszewska A; Wiland P
Arch Immunol Ther Exp (Warsz); 2015 Oct; 63(5):397-404. PubMed ID: 25837853
[TBL] [Abstract][Full Text] [Related]
20. Gingival crevicular fluid, serum levels of receptor activator of nuclear factor-κB ligand, osteoprotegerin, and interleukin-17 in patients with rheumatoid arthritis and osteoporosis and with periodontal disease.
Gümüş P; Buduneli E; Bıyıkoğlu B; Aksu K; Saraç F; Nile C; Lappin D; Buduneli N
J Periodontol; 2013 Nov; 84(11):1627-37. PubMed ID: 23327689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
